Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer

Liquid biopsies, examinations of tumor components in body fluids, have shown promise for predicting clinical outcomes. To evaluate tumor-associated genomic and genetic variations in plasma cell-free DNA (cfDNA) and their associations with treatment response and overall survival, we applied whole gen...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Xia, Shu, Kohli, Manish, Du, Meijun, Dittmar, Rachel L., Lee, Adam, Nandy, Debashis, Yuan, Tiezheng, Guo, Yongchen, Wang, Yuan, Tschannen, Michael R., Worthey, Elizabeth, Jacob, Howard, See, William, Kilari, Deepak, Wang, Xuexia, Hovey, Raymond L., Huang, Chiang-Ching, Wang, Liang
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2015
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4599278/
https://ncbi.nlm.nih.gov/pubmed/25915538
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars